Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KMA Holding, Inc. is a Florida-based medical technology company and diversified holding group specializing in rapid diagnostic solutions and emergency medical infrastructure. Through its subsidiary, Lyfetec, Inc., the company develops and manufactures a comprehensive range of over-the-counter home medical test kits for both human and veterinary use, targeting the early detection of cancer, infectious diseases, and sexually transmitted infections. KMA Holding also operates an Emergency Medical Response Mobile Hospital Unit (ERHU) division, which provides deployable temporary life-support systems equipped with secured wireless communication for crisis management. In addition to its healthcare core, the company maintains interests in the mineral rights and firearms industries, reflecting its origin as a diversified business development vehicle. Headquartered in Pompano Beach, the company is publicly traded on the OTC market under the symbol MCDA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KMA Holding.